Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion‐dependent thalassemia: A randomized controlled trial

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 262-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis E infection in a patient with transfusion‐dependent β thalassemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : E50-E50

John Wiley & Sons Inc

Access to resources Recommend Favorite

Activity of cytochrome P450 1A2 in relation to hepatic iron accumulation in transfusion‐dependent β‐thalassaemia major patients

By  

VOX SANGUINIS, Vol. 108, Iss. 3, 2015-04 ,pp. : 268-273

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-Dependent Thalassaemia

By  

Current Drug Safety, Vol. 11, Iss. 2, 2016-04 ,pp. : 137-144

Bentham Science Publishers

Access to resources Recommend Favorite

Premature Atherosclerosis in Non-Transfusion-Dependent β-Thalassemia Intermedia

By  

Cardiology, Vol. 118, Iss. 3, 2011-06 ,pp. : 159-163

Karger

Access to resources Recommend Favorite